Comparison Between Alpelisib Plus Endocrine Therapy and Everolimus Plus Endocrine Therapy After CDK4/6 Inhibitors Progression in Patients with &lt;i&gt;PIK3CA&lt;/i&gt;-Mutant Metastatic Breast Cancer: A Single-Center Retrospective Study. This evidence concerns the gene CDK4 and breast carcinoma.